Back to SMG
SMG: Dividend Income, Guidance, and Leverage
$SMGNEUTRALAgricultural Inputs

SMG: Dividend Income, Guidance, and Leverage

SMG shows a mixed picture heading into the long weekend. Analysts are constructive with a mean target near $76, but a Q4 loss, high debt and negative ROE highlight execution and balance sheet risks investors should monitor.

November 7, 202611 min read
Current Price
$64.71
-2.52%
Analyst Rating
Strong Buy
Price Target
$76.33
18.0% upside
P/E Ratio
36.35

Executive Summary

Investment Thesis: The Scotts Miracle-Gro Company ($SMG) combines a high-yielding dividend and positive fiscal 2026 commentary with an analyst consensus that favors upside, but the company faces near-term earnings volatility, high leverage, and working-capital pressure. Management beat a tough Q4 EPS comparison slightly, while full-year non-GAAP results and guidance point to recovery potential. Given mixed fundamentals and valuation divergence between trailing and forward multiples, the risk/reward looks balanced rather than one-sided.

Current Price: $64.71 as of Friday, November 6 | Key Metric: Dividend Yield 4.08% | Stance: NEUTRAL

Company Overview

The Scotts Miracle-Gro Company ($SMG) is a leading consumer lawn and garden products company in North America. It manufactures and markets consumer fertilizers, grass seed, pest control, and related horticultural products, and it has expanding exposure to indoor gardening categories through focused brands.

Key Products & Competitive Position

  • Core Business: Consumer lawn and garden inputs sold through mass and specialty retailers plus growing indoor gardening offerings.
  • Key Products: Lawn fertilizers, grass seed, pest control, hydroponic and indoor gardening systems, and branded accessories.
  • Competitive Moat: Strong brand recognition and retail shelf placement, broad product portfolio, and distribution relationships that make it hard for smaller brands to replicate scale.

Recent Developments

SMG reported fiscal Q4 2026 results on November 4, 2026 with a GAAP EPS loss of $2.16 that narrowly beat consensus of a $2.21 loss. The company released fiscal 2026 full-year results that management characterized as strong on a non-GAAP basis, with expanded gross margins and adjusted EPS above guidance. The Board approved a quarterly dividend announced November 3, 2026. Management reiterated fiscal 2027 guidance calling for top-line and bottom-line growth. The company is operating with elevated debt and a lean cash position by comparison to short-term obligations, while free cash flow remained positive over the trailing period.

Financial Snapshot

Market Cap$3.77B
P/E Ratio36.35
52-Week Range$47.90 - $75.34
Dividend Yield4.08%
EPS (TTM)$1.79
ROE-30.38%

Revenue & Earnings Trends

Trailing 12-month revenue is roughly $3.29B, down about 21.8% year over year per available data. The Q4 2026 quarter produced a GAAP EPS loss, but it beat consensus slightly. Management reported improved gross margins and non-GAAP adjusted EPS that exceeded fiscal 2026 guidance. Operating margins are reported negative on a GAAP basis, driven by the quarterly loss and nonrecurring items in the period, while EBITDA and operating cash flow remain positive at roughly $511M and $373M respectively.

Balance Sheet Highlights

SMG carries meaningful leverage, with total debt around $2.03B and a cash balance that appears minimal at roughly $7.4M in the extracted snapshot. The current ratio of 1.22 suggests the company meets short-term obligations, but the quick ratio near 0.20 points to inventory as the dominant current asset. Free cash flow over the lookback period was positive at roughly $338.6M, which helps service debt and dividends but does not eliminate balance sheet sensitivity to margin or working capital shocks.

Valuation Analysis

Current Valuation Metrics

Forward P/E12.46vs Industry: ~15-18
PEG Ratio1.25Growth-adjusted (assumes ~10% EPS CAGR)
EV/EBITDA~11.3vs Historical: ~9.0
P/S Ratio~1.15vs Peers: ~1.8-2.0

Historical Comparison

Trailing P/E based on the provided EPS is elevated at 36.35, while the forward P/E from consensus estimates is much lower at about 12.5. That divergence reflects either a trough in recent GAAP earnings or material expected earnings improvement next fiscal year. Compared with a five-year average multiple for the company, current valuations sit in the mid-range when using forward multiples but above average on a trailing-GAAP basis due to recent volatility in earnings.

Fair Value Estimate

Blending the mean analyst price target of $76.33 with a multiples framework and a conservative DCF sensitivity that values the business at a forward multiple closer to 12x-14x, a midpoint fair value estimate is approximately $75. This implies roughly 16% potential upside from the $64.71 level as of Friday, November 6 when using the median assumptions. The estimate is sensitive to assumed margin normalization and working capital trends.

Competitive Landscape

Market Position

Market Share: Leading share in North American consumer lawn & garden inputs | Ranking: #1 in many mass retail shelf categories for lawn and garden

Key Competitors

The Mosaic (MOS)Supplier of potash and phosphate fertilizers to agricultural markets
$NTRGlobal fertilizer company with broad crop nutrient exposure
CF Industries (CF)Large-scale fertilizer and chemical producer serving agriculture

Competitive Advantages

  • Moat 1: Brand equity across consumer categories, which sustains pricing power in retail channels.
  • Moat 2: Deep retailer relationships and shelf presence that create distribution stickiness.
  • Moat 3: Product breadth across seasonal categories and recent investments in indoor/hydroponic segments that diversify demand drivers.

Earnings Track Record

Last 4 Quarters: 2 beats / 2 misses

Recent Earnings History

Q4 2026$-2.16 vs $-2.21 estBEAT
FY 2026 (full-year)Adjusted EPS above guidanceBEAT
Q3 2026(Prior quarter noise)MIXED
Q2 2026(Variable results across channels)MIXED

Guidance Trend

Management provided fiscal 2027 guidance calling for revenue and adjusted EPS growth. Analysts are modeling meaningful recovery in GAAP results next fiscal year which is why forward multiples compress relative to trailing GAAP. Execution against guidance, particularly in margin expansion and working-capital management, will be the key validation point.

Analyst Sentiment

Consensus Rating: Strong Buy

Strong Buy: 1 Buy: 5 Hold: 2 Sell: 0

Price Targets

  • Low: $75
  • Mean: $76.33 (+18.0% upside)
  • High: $78

Recent Analyst Actions

Analysts have largely maintained a constructive view following the Q4 print and fiscal 2026 release. The consensus leans toward upside based on management's guidance and the expectation of margin recovery. Analysts note that valuation reflects a recovery scenario and that downside exists if margins or working capital fail to normalize.

Recent News & Catalysts

Key Developments

  • Q4 2026 Earnings Call (11/4/2026): Management discussed fiscal 2026 results, margin improvement on a non-GAAP basis, and fiscal 2027 guidance calling for revenue and EPS growth, according to Seeking Alpha transcript highlights.
  • Q4 Headline Metrics Coverage: Zacks research highlighted Q4 metrics and suggested comparing sell-through and inventory changes to better gauge channel health.
  • Dividend Announcement (11/3/2026): Board declared a quarterly dividend, supporting income-focused investor interest and signaling confidence in cash generation.

Upcoming Catalysts

Next Earnings: Expected 2027-01-27 | Key Events: Management commentary on fiscal 2027 outlook, margin trajectory, inventory and working capital trends, and any updates to capital allocation plans.

Technical Outlook

Current Price: $64.71 as of Friday, November 6 vs 52-Week High: $75.34 (-14.1% from high)

Trend Analysis

SMG has recovered from its 52-week low of $47.90 and is trading well below the all-time highs set earlier in the decade. Short-term momentum improved over the last month with a notable one-month return near 28% according to market data, but the stock has shown volatility driven by seasonal demand dynamics and quarterly earnings swings. The beta of 1.85 implies above-market sensitivity to equity moves.

Key Levels

  • Resistance: $72, $75
  • Support: $60, $48

Bull vs Bear Case

Bull Case

  • Catalyst 1: Management guidance and execution drive margin normalization and revenue growth, validating the forward P/E compression and analyst targets.
  • Catalyst 2: A 4% dividend yield plus stable free cash flow makes the equity attractive to income-oriented investors while deleveraging occurs.
  • Catalyst 3: Continued expansion into indoor gardening and branded offerings increases addressable market and provides higher-margin product mixes.

Bull Target: $90 (+39% from $64.71)

Bear Case

  • Risk 1: Earnings volatility continues as inventory obsolescence, retailer destocking, or softer consumer lawn demand pressures margins and cash conversion.
  • Risk 2: High debt and minimal cash raise refinancing or covenant risk if free cash flow weakens, which could compress equity valuations.
  • Risk 3: Valuation may already price a recovery. If guidance disappoints, downside to current price could be material given the leverage and seasonality.

Bear Target: $50 (-22% from $64.71)

Risks to Consider

  • Valuation Risk: Trailing P/E of 36.35 contrasts with a forward P/E near 12.5. If forward earnings estimates are optimistic, multiple compression could lead to downside.
  • Competitive Risk: Private label and low-cost brands in mass retail channels can pressure pricing and market share, especially in a slower consumer spending environment.
  • Macro Risk: Consumer discretionary weakness, unusual weather patterns, or a slowdown in housing and lawn care activity could materially impact seasonal demand.
  • Execution Risk: Working-capital management, inventory turns, and integration of new product channels are key execution items. Misses on these fronts historically drive abrupt earnings revisions.

Bottom Line

Investment Verdict: NEUTRAL

Data suggests a mixed outlook for $SMG. Analysts are generally positive and the company is guiding to growth, while the dividend yield and positive free cash flow are supportive. At the same time, Q4 GAAP losses, negative ROE, and a leveraged balance sheet increase downside risk if execution slips. You'll want to see consistent margin improvement and working-capital normalization before treating the recovery narrative as secured.

Action Items for Investors

  • Long-term investors: Monitor quarterly progress on margin expansion, debt reduction, and the cadence of free cash flow relative to dividends and buybacks. Track ex-dividend date and payout sustainability.
  • Short-term traders: Watch near-term technical levels at $60 and $72 and trade around volatility, keeping position sizes aligned with the companys high beta.
  • Risk management: Consider setting stop-loss thresholds or laddered position sizing given earnings sensitivity and leverage. Analysts note that downside could be sharp if guidance is missed.

What to Watch This Week

  • Monitor analyst note flow and any revisions following the November 4 earnings print and the dividend announcement.
  • Keep an eye on trading volume and price action when markets reopen Monday, November 9, as investors digest quarter-end flows heading into the long weekend.
  • Track inventory and retailer commentary that can appear in trade publications and industry reports, which will help validate sell-through improvements cited by management.

Share this report

Share this article

Spread the word on social media

Think SMG will outperform? Prove it.

Free practice contests — earn Alpha Coins
Enter a Contest

Disclaimer: StockAlpha.ai content is for informational and educational purposes only. It is not personalized investment advice. Sentiment ratings and market analysis reflect data-driven observations, not buy, sell, or hold recommendations. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.

Spotted something wrong? Report an error.